Neurology® Podcast
Dr. Stacey Clardy talks with Dr. Bhooma Aravamuthan about the modern definition of cerebral palsy, the philosophical implications of diagnostic labels, and the need for clarity in clinical practice. Read the related article in . Disclosures can be found at .
info_outline December 2024 Recall: Topics in Autoimmune NeurologyNeurology® Podcast
The December 2024 replay wraps up the year with five previously posted episodes on autoimmune neurology. The episode begins with Drs. Michael R. Wilson and John Pluvinage discussing transcobalamin antibodies. The episode leads into an interview with Dr. Andrew McKeon, who talks about paraneoplastic CAMKV autoimmune encephalitis. In the third episode, Dr. Maarten Titulaer discusses long-term outcomes and rehab in NMDAR encephalitis. The episode continues with Prof. Zsolt Illes discussing the mortality of patients with AQP4 antibody–seropositive neuromyelitis optica spectrum disorder compared...
info_outline Understanding Acute Symptomatic SeizuresNeurology® Podcast
Dr. Halley Alexander talks with Dr. Vineet Punia about factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. Read the related article in . Disclosures can be found at .
info_outline Features of Educational Social Media PostsNeurology® Podcast
Dr. Stacey Clardy talks with Dr. Catherine Albin about the key features of educational social media posts, strategies for creating impactful content, the importance of visual appeal, and the role of community engagement in neurology education. Read the related article in . Disclosures can be found at .
info_outline Long-Term Outcomes and Rehabilitation in Anti-NMDAR EncephalitisNeurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Maarten Titulaer about long-term cognitive and functional outcomes in patients with anti-NMDAR encephalitis and their implications for rehabilitation. Read the related article in . Disclosures can be found at .
info_outline Myelitis Associated With Rheumatologic DiseaseNeurology® Podcast
Dr. Stacey Clardy talks with Dr. Elias Sotirchos about the underlying etiologies of myelitis in patients with rheumatologic disease. Read the related article in . Disclosures can be found at Neurology.org.
info_outline The Placebo EffectNeurology® Podcast
Dr. Gregg Day talks with Dr. Kathryn T. Hall about the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments. Disclosures can be found at .
info_outline CAA-RI and Biopsy-Positive Primary Angiitis of the CNSNeurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Ahmad Nehme about the complexities of diagnosing and differentiating between cerebral amyloid angiopathy-related inflammation and biopsy-positive primary angiitis of the central nervous system. Read the related article in . Disclosures can be found at .
info_outline Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2Neurology® Podcast
In the concluding segment of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about genetic leukodystrophies and the increasing recognition of these disorders in adult neurology, the importance of genetic testing, and the evolving treatment landscape. Read the related articles in and . Disclosures can be found at Neurology.org.
info_outline Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1Neurology® Podcast
In the first part of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about a practical approach to genetic leukodystrophies, focusing on the importance of genetic testing, identifying red flags in patients, and navigating the complexities of hereditary spastic paraplegia. Read the related articles in and . Disclosures can be found at .
info_outlineDr. Gordon Smith talks with Drs. Ruben P.A. van Eijk and Jordi van Unnik about the planning of interim analyses for clinical trials in ALS to maximize patient safety and minimize exposure to ineffective or harmful drugs.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.